Q3KL32 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibbnos2q7q7cb6nwwa2zwixlecitmyrehqynbmedwwg4lgxbigwbm/metadata.json
IPFS of structure file: 
bafybeidp4wgpq3r3vyxzn5iqry4r4chxbhari5elcucybzl6gabl6vrdoe/AF-Q3KL32-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x4E070bf86B2e4C96C5645E88AdD4a62f9Eb2755d
First NFT owner address (bech32): 
genesis1fcrsh7rt9exfd3tyt6y2m49x970tya2azrtgsj
Current NFT ID #166538 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
166538
Accession (UniProt):
Q3KL32
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Chlamydia trachomatis serovar A (strain ATCC VR-571B / DSM 19440 / HAR-13)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q3KL32 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q3KL32|HEM1_CHLTA Glutamyl-tRNA reductase OS=Chlamydia trachomatis serovar A (strain ATCC VR-571B / DSM 19440 / HAR-13) OX=315277 GN=hemA PE=3 SV=1 MVREGEERIGNRVSLGVIGVSYRETTLQQREQVLHILQQAQGSFRLEVFQEEKDYVLLATCHRVELYSVAPAELFDSLAQEIELLGVSPYFYRNQDCFAHLFCVAGGLDSLVLGETEIQGQVKRAYLQAAREQKLSFALHFLFQKALKEGKVFRAKGGAPYAEITIPILVDQELRRRQIDKKASLLFIGYSEINRSVAYHLQRQGFSCITFCSRQQLPTLSMRQVVREELCFQDPYRVVFLGSSELQYALPHSLWESIWDIPDRIVFDFAVPRALPSHTVFPHRYVDMDQISDWLREHRKEVNSAHLHSLREVAYRYWNSLNQRLERRDCVGANA